Global and Japan Enzalutamide Tablets Market Report & Forecast 2024-2030

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Enzalutamide is an active pharmaceutical ingredient (API) used primarily in the treatment of prostate cancer. It is an androgen receptor inhibitor that works by blocking the action of androgens (male hormones like testosterone) on cancer cells, which can help slow the growth and spread of tumors.

The global Enzalutamide Tablets revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).

In Japan the Enzalutamide Tablets revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).

This report focuses on global and Japan Enzalutamide Tablets market, also covers the segmentation data of other regions in regional level and county level.

The global key players of Enzalutamide Tablets include Astellas/Pfizer, AURISCO, etc. The global five biggest players hold a share of % in 2023.

Enzalutamide Tablets market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Enzalutamide Tablets market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.

For Japan market, this report focuses on the Enzalutamide Tablets market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in Japan.

Market Segmentation

Chapter Outline
Chapter 1: Introduces Enzalutamide Tablets definition, global sales (volume and revenue), Japan market size, Japan percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Enzalutamide Tablets companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue and volume of Enzalutamide Tablets in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world. 
Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Enzalutamide Tablets sales, revenue, gross margin, and recent development, etc.
Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12: research findings and conclusion

 1 Study Coverage
    1.1 Enzalutamide Tablets Product Introduction
    1.2 Global Enzalutamide Tablets Outlook 2019 VS 2023 VS 2030
        1.2.1 Global Enzalutamide Tablets Sales in US$ Million for the Year 2019-2030
        1.2.2 Global Enzalutamide Tablets Sales in Volume for the Year 2019-2030
    1.3 Japan Enzalutamide Tablets Outlook 2019 VS 2023 VS 2030
        1.3.1 Japan Enzalutamide Tablets Sales in US$ Million for the Year 2019-2030
        1.3.2 Japan Enzalutamide Tablets Sales in Volume for the Year 2019-2030
    1.4 Enzalutamide Tablets Market Size, Japan VS Global, 2019 VS 2023 VS 2030
        1.4.1 The Market Share of Japan Enzalutamide Tablets in Global, 2019 VS 2023 VS 2030
        1.4.2 The Growth Rate of Enzalutamide Tablets Market Size, Japan VS Global, 2019 VS 2023 VS 2030
    1.5 Enzalutamide Tablets Market Dynamics
        1.5.1 Enzalutamide Tablets Industry Trends
        1.5.2 Enzalutamide Tablets Market Drivers
        1.5.3 Enzalutamide Tablets Market Challenges
        1.5.4 Enzalutamide Tablets Market Restraints
    1.6 Assumptions and Limitations
    1.7 Study Objectives
    1.8 Years Considered

 2 Enzalutamide Tablets by Type
    2.1 Enzalutamide Tablets Market by Type
        2.1.1 40mg
        2.1.2 80mg
    2.2 Global Enzalutamide Tablets Market Size by Type
        2.2.1 Global Enzalutamide Tablets Sales in Value, by Type (2019, 2023 & 2030)
        2.2.2 Global Enzalutamide Tablets Sales in Volume, by Type (2019, 2023 & 2030)
        2.2.3 Global Enzalutamide Tablets Average Selling Price (ASP) by Type (2019, 2023 & 2030)
    2.3 Japan Enzalutamide Tablets Market Size by Type
        2.3.1 Japan Enzalutamide Tablets Sales in Value, by Type (2019, 2023 & 2030)
        2.3.2 Japan Enzalutamide Tablets Sales in Volume, by Type (2019, 2023 & 2030)
        2.3.3 Japan Enzalutamide Tablets Average Selling Price (ASP) by Type (2019, 2023 & 2030)

 3 Enzalutamide Tablets by Application
    3.1 Enzalutamide Tablets Market by Application
        3.1.1 Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
        3.1.2 Castration- Resistant Prostate Cancer (NM-CRPC)
    3.2 Global Enzalutamide Tablets Market Size by Application
        3.2.1 Global Enzalutamide Tablets Sales in Value, by Application (2019, 2023 & 2030)
        3.2.2 Global Enzalutamide Tablets Sales in Volume, by Application (2019, 2023 & 2030)
        3.2.3 Global Enzalutamide Tablets Average Selling Price (ASP) by Application (2019, 2023 & 2030)
    3.3 Japan Enzalutamide Tablets Market Size by Application
        3.3.1 Japan Enzalutamide Tablets Sales in Value, by Application (2019, 2023 & 2030)
        3.3.2 Japan Enzalutamide Tablets Sales in Volume, by Application (2019, 2023 & 2030)
        3.3.3 Japan Enzalutamide Tablets Average Selling Price (ASP) by Application (2019, 2023 & 2030)

 4 Global Enzalutamide Tablets Competitor Landscape by Company
    4.1 Global Enzalutamide Tablets Market Size by Company
        4.1.1 Global Key Manufacturers of Enzalutamide Tablets, Ranked by Revenue (2023)
        4.1.2 Global Enzalutamide Tablets Revenue by Manufacturer (2019-2024)
        4.1.3 Global Enzalutamide Tablets Sales by Manufacturer (2019-2024)
        4.1.4 Global Enzalutamide Tablets Price by Manufacturer (2019-2024)
    4.2 Global Enzalutamide Tablets Concentration Ratio (CR)
        4.2.1 Enzalutamide Tablets Market Concentration Ratio (CR) (2019-2024)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Enzalutamide Tablets in 2023
        4.2.3 Global Enzalutamide Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Key Manufacturers of Enzalutamide Tablets, Manufacturing Base Distribution and Headquarters
    4.4 Global Key Manufacturers of Enzalutamide Tablets, Product Offered and Application
    4.5 Global Key Manufacturers of Enzalutamide Tablets, Date of Enter into This Industry
    4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.7 Japan Enzalutamide Tablets Market Size by Company
        4.7.1 Key Players of Enzalutamide Tablets in Japan, Ranked by Revenue (2023)
        4.7.2 Japan Enzalutamide Tablets Revenue by Players (2019-2024)
        4.7.3 Japan Enzalutamide Tablets Sales by Players (2019-2024)

 5 Global Enzalutamide Tablets Market Size by Region
    5.1 Global Enzalutamide Tablets Market Size by Region: 2019 VS 2023 VS 2030
    5.2 Global Enzalutamide Tablets Market Size in Volume by Region (2019-2030)
        5.2.1 Global Enzalutamide Tablets Sales in Volume by Region: 2019-2024
        5.2.2 Global Enzalutamide Tablets Sales in Volume Forecast by Region (2025-2030)
    5.3 Global Enzalutamide Tablets Market Size in Value by Region (2019-2030)
        5.3.1 Global Enzalutamide Tablets Sales in Value by Region: 2019-2024
        5.3.2 Global Enzalutamide Tablets Sales in Value by Region: 2025-2030

 6 Americas
    6.1 Americas Enzalutamide Tablets Market Size YoY Growth 2019-2030
    6.2 Americas Enzalutamide Tablets Sales in Volume, by Type (2019, 2023 & 2030)
    6.3 Americas Enzalutamide Tablets Sales in Volume, by Application (2019, 2023 & 2030)
    6.4 Americas Enzalutamide Tablets Market Facts & Figures by Country (2019, 2023 & 2030)
        6.4.1 Americas Enzalutamide Tablets Sales in Value by Country (2019, 2023 & 2030)
        6.4.2 Americas Enzalutamide Tablets Sales in Volume by Country (2019, 2023 & 2030)
        6.4.3 United States
        6.4.4 Canada
        6.4.5 Mexico
        6.4.6 Brazil

 7 EMEA
    7.1 EMEA Enzalutamide Tablets Market Size YoY Growth 2019-2030
    7.2 EMEA Enzalutamide Tablets Sales in Volume, by Type (2019, 2023 & 2030)
    7.3 EMEA Enzalutamide Tablets Sales in Volume, by Application (2019, 2023 & 2030)
    7.4 EMEA Enzalutamide Tablets Market Facts & Figures by Country (2019, 2023 & 2030)
        7.4.1 EMEA Enzalutamide Tablets Sales in Value by Country (2019, 2023 & 2030)
        7.4.2 EMEA Enzalutamide Tablets Sales in Volume by Country (2019, 2023 & 2030)
        7.4.3 Europe
        7.4.4 Middle East
        7.4.5 Africa

 8 China
    8.1 China Enzalutamide Tablets Market Size YoY Growth 2019-2030
    8.2 China Enzalutamide Tablets Sales in Volume, by Type (2019, 2023 & 2030)
    8.3 China Enzalutamide Tablets Sales in Volume, by Application (2019, 2023 & 2030)

 9 APAC
    9.1 APAC Enzalutamide Tablets Market Size YoY Growth 2019-2030
    9.2 APAC Enzalutamide Tablets Sales in Volume, by Type (2019, 2023 & 2030)
    9.3 APAC Enzalutamide Tablets Sales in Volume, by Application (2019, 2023 & 2030)
    9.4 APAC Enzalutamide Tablets Market Facts & Figures by Country (2019, 2023 & 2030)
        9.4.1 APAC Enzalutamide Tablets Sales in Value by Country (2019, 2023 & 2030)
        9.4.2 APAC Enzalutamide Tablets Sales in Volume by Country (2019, 2023 & 2030)
        9.4.3 Japan
        9.4.4 South Korea
        9.4.5 China Taiwan
        9.4.6 Southeast Asia
        9.4.7 India

 10 Company Profiles
    10.1 Astellas/Pfizer
        10.1.1 Astellas/Pfizer Company Information
        10.1.2 Astellas/Pfizer Description and Business Overview
        10.1.3 Astellas/Pfizer Enzalutamide Tablets Sales, Revenue and Gross Margin (2019-2024)
        10.1.4 Astellas/Pfizer Enzalutamide Tablets Products Offered
        10.1.5 Astellas/Pfizer Recent Development
    10.2 AURISCO
        10.2.1 AURISCO Company Information
        10.2.2 AURISCO Description and Business Overview
        10.2.3 AURISCO Enzalutamide Tablets Sales, Revenue and Gross Margin (2019-2024)
        10.2.4 AURISCO Enzalutamide Tablets Products Offered
        10.2.5 AURISCO Recent Development

 11 Industry Chain and Sales Channels Analysis
    11.1 Enzalutamide Tablets Industry Chain Analysis
    11.2 Enzalutamide Tablets Key Raw Materials
        11.2.1 Key Raw Materials
        11.2.2 Raw Materials Key Suppliers
    11.3 Enzalutamide Tablets Production Mode & Process
    11.4 Enzalutamide Tablets Sales and Marketing
        11.4.1 Enzalutamide Tablets Sales Channels
        11.4.2 Enzalutamide Tablets Distributors
    11.5 Enzalutamide Tablets Customers

 12 Research Findings and Conclusion

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
            13.1.1.1 Research Programs/Design
            13.1.1.2 Market Size Estimation
            13.1.1.3 Market Breakdown and Data Triangulation
        13.1.2 Data Source
            13.1.2.1 Secondary Sources
            13.1.2.2 Primary Sources
    13.2 Author Details
    13.3 Disclaimer

List of Tables
 Table 1. Enzalutamide Tablets CAGR in Value, Japan VS Global, 2019 VS 2023 VS 2030
 Table 2. Enzalutamide Tablets Market Trends
 Table 3. Enzalutamide Tablets Market Drivers
 Table 4. Enzalutamide Tablets Market Challenges
 Table 5. Enzalutamide Tablets Market Restraints
 Table 6. Global Enzalutamide Tablets Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)
 Table 7. Japan Enzalutamide Tablets Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)
 Table 8. Global Enzalutamide Tablets Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)
 Table 9. Japan Enzalutamide Tablets Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)
 Table 10. Global Key Manufacturers of Enzalutamide Tablets, Ranked by Revenue (2023) & (US$ Million)
 Table 11. Global Enzalutamide Tablets Revenue by Manufacturer, (US$ Million) & (2019-2024)
 Table 12. Global Enzalutamide Tablets Revenue Share by Manufacturer, 2019-2024
 Table 13. Global Enzalutamide Tablets Sales by Manufacturer, (K Units), 2019-2024
 Table 14. Global Enzalutamide Tablets Sales Share by Manufacturer, 2019-2024
 Table 15. Global Enzalutamide Tablets Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 16. Global Enzalutamide Tablets Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 17. Global Enzalutamide Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enzalutamide Tablets as of 2023)
 Table 18. Global Key Manufacturers of Enzalutamide Tablets, Manufacturing Base Distribution and Headquarters
 Table 19. Global Key Manufacturers of Enzalutamide Tablets, Product Offered and Application
 Table 20. Global Key Manufacturers of Enzalutamide Tablets, Date of Enter into This Industry
 Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 22. Key Players of Enzalutamide Tablets in Japan, Ranked by Revenue (2023) & (US$ million)
 Table 23. Japan Enzalutamide Tablets Revenue by Players, (US$ Million) & (2019-2024)
 Table 24. Japan Enzalutamide Tablets Revenue Share by Players, (2019-2024)
 Table 25. Japan Enzalutamide Tablets Sales by Players, (K Units) & (2019-2024)
 Table 26. Japan Enzalutamide Tablets Sales Share by Players, (2019-2024)
 Table 27. Global Enzalutamide Tablets Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 28. Global Enzalutamide Tablets Sales in Volume by Region (2019-2024) & (K Units)
 Table 29. Global Enzalutamide Tablets Sales in Volume Forecast by Region (2025-2030) & (K Units)
 Table 30. Global Enzalutamide Tablets Sales in Value by Region (2019-2024) & (US$ Million)
 Table 31. Global Enzalutamide Tablets Sales in Value Forecast by Region (2025-2030) & (US$ Million)
 Table 32. Americas Enzalutamide Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. Americas Enzalutamide Tablets Sales in Value by Country (2019-2024) & (US$ Million)
 Table 34. Americas Enzalutamide Tablets Sales in Value by Country (2025-2030) & (US$ Million)
 Table 35. Americas Enzalutamide Tablets Sales in Volume by Country (2019-2024) & (K Units)
 Table 36. Americas Enzalutamide Tablets Sales in Volume by Country (2025-2030) & (K Units)
 Table 37. EMEA Enzalutamide Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. EMEA Enzalutamide Tablets Sales in Value by Country (2019-2024) & (US$ Million)
 Table 39. EMEA Enzalutamide Tablets Sales in Value by Country (2025-2030) & (US$ Million)
 Table 40. EMEA Enzalutamide Tablets Sales in Volume by Country (2019-2024) & (K Units)
 Table 41. EMEA Enzalutamide Tablets Sales in Volume by Country (2025-2030) & (K Units)
 Table 42. APAC Enzalutamide Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. APAC Enzalutamide Tablets Sales in Value by Country (2019-2024) & (US$ Million)
 Table 44. APAC Enzalutamide Tablets Sales in Value by Country (2025-2030) & (US$ Million)
 Table 45. APAC Enzalutamide Tablets Sales in Volume by Country (2019-2024) & (K Units)
 Table 46. APAC Enzalutamide Tablets Sales in Volume by Country (2025-2030) & (K Units)
 Table 47. Astellas/Pfizer Company Information
 Table 48. Astellas/Pfizer Description and Business Overview
 Table 49. Astellas/Pfizer Enzalutamide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 50. Astellas/Pfizer Enzalutamide Tablets Product
 Table 51. Astellas/Pfizer Recent Development
 Table 52. AURISCO Company Information
 Table 53. AURISCO Description and Business Overview
 Table 54. AURISCO Enzalutamide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 55. AURISCO Enzalutamide Tablets Product
 Table 56. AURISCO Recent Development
 Table 57. Key Raw Materials Lists
 Table 58. Raw Materials Key Suppliers Lists
 Table 59. Enzalutamide Tablets Distributors List
 Table 60. Enzalutamide Tablets Customers List
 Table 61. Research Programs/Design for This Report
 Table 62. Key Data Information from Secondary Sources
 Table 63. Key Data Information from Primary Sources


List of Figures
 Figure 1. Enzalutamide Tablets Product Picture
 Figure 2. Global Enzalutamide Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 3. Global Enzalutamide Tablets Market Size 2019-2030 (US$ Million)
 Figure 4. Global Enzalutamide Tablets Sales 2019-2030 (K Units)
 Figure 5. Japan Enzalutamide Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 6. Japan Enzalutamide Tablets Market Size 2019-2030 (US$ Million)
 Figure 7. Japan Enzalutamide Tablets Sales 2019-2030 (K Units)
 Figure 8. Japan Enzalutamide Tablets Market Share in Global, in Value (US$ Million) 2019-2030
 Figure 9. Japan Enzalutamide Tablets Market Share in Global, in Volume (K Units) 2019-2030
 Figure 10. Enzalutamide Tablets Report Years Considered
 Figure 11. Product Picture of 40mg
 Figure 12. Product Picture of 80mg
 Figure 13. Global Enzalutamide Tablets Market Share by Type in 2023 & 2030
 Figure 14. Global Enzalutamide Tablets Sales in Value by Type (2019-2030) & (US$ Million)
 Figure 15. Global Enzalutamide Tablets Sales Market Share in Value by Type (2019-2030)
 Figure 16. Global Enzalutamide Tablets Sales by Type (2019-2030) & (K Units)
 Figure 17. Global Enzalutamide Tablets Sales Market Share in Volume by Type (2019-2030)
 Figure 18. Global Enzalutamide Tablets Price by Type (2019-2030) & (US$/Unit)
 Figure 19. Japan Enzalutamide Tablets Market Share by Type in 2023 & 2030
 Figure 20. Japan Enzalutamide Tablets Sales in Value by Type (2019-2030) & (US$ Million)
 Figure 21. Japan Enzalutamide Tablets Sales Market Share in Value by Type (2019-2030)
 Figure 22. Japan Enzalutamide Tablets Sales by Type (2019-2030) & (K Units)
 Figure 23. Japan Enzalutamide Tablets Sales Market Share in Volume by Type (2019-2030)
 Figure 24. Japan Enzalutamide Tablets Price by Type (2019-2030) & (US$/Unit)
 Figure 25. Product Picture of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
 Figure 26. Product Picture of Castration- Resistant Prostate Cancer (NM-CRPC)
 Figure 27. Global Enzalutamide Tablets Market Share by Application in 2023 & 2030
 Figure 28. Global Enzalutamide Tablets Sales in Value by Application (2019-2030) & (US$ Million)
 Figure 29. Global Enzalutamide Tablets Sales Market Share in Value by Application (2019-2030)
 Figure 30. Global Enzalutamide Tablets Sales by Application (2019-2030) & (K Units)
 Figure 31. Global Enzalutamide Tablets Sales Market Share in Volume by Application (2019-2030)
 Figure 32. Global Enzalutamide Tablets Price by Application (2019-2030) & (US$/Unit)
 Figure 33. Japan Enzalutamide Tablets Market Share by Application in 2023 & 2030
 Figure 34. Japan Enzalutamide Tablets Sales in Value by Application (2019-2030) & (US$ Million)
 Figure 35. Japan Enzalutamide Tablets Sales Market Share in Value by Application (2019-2030)
 Figure 36. Japan Enzalutamide Tablets Sales by Application (2019-2030) & (K Units)
 Figure 37. Japan Enzalutamide Tablets Sales Market Share in Volume by Application (2019-2030)
 Figure 38. Japan Enzalutamide Tablets Price by Application (2019-2030) & (US$/Unit)
 Figure 39. The Top 5 and 10 Largest Manufacturers of Enzalutamide Tablets in the World: Market Share by Enzalutamide Tablets Revenue in 2023
 Figure 40. Global Enzalutamide Tablets Market Size Market Share by Region: 2019 VS 2023 VS 2030
 Figure 41. Global Enzalutamide Tablets Sales in Volume Market Share by Region (2019-2030)
 Figure 42. Global Enzalutamide Tablets Sales in Value Market Share by Region (2019-2030)
 Figure 43. Americas Enzalutamide Tablets Sales in Volume Growth Rate 2019-2030 (K Units)
 Figure 44. Americas Enzalutamide Tablets Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 45. Americas Enzalutamide Tablets Sales by Type (2019-2030) & (K Units)
 Figure 46. Americas Enzalutamide Tablets Sales Market Share in Volume by Type (2019-2030)
 Figure 47. Americas Enzalutamide Tablets Sales by Application (2019-2030) & (K Units)
 Figure 48. Americas Enzalutamide Tablets Sales Market Share in Volume by Application (2019-2030)
 Figure 49. United States Enzalutamide Tablets Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Canada Enzalutamide Tablets Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Mexico Enzalutamide Tablets Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Brazil Enzalutamide Tablets Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 53. EMEA Enzalutamide Tablets Sales in Volume Growth Rate 2019-2030 (K Units)
 Figure 54. EMEA Enzalutamide Tablets Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 55. EMEA Enzalutamide Tablets Sales by Type (2019-2030) & (K Units)
 Figure 56. EMEA Enzalutamide Tablets Sales Market Share in Volume by Type (2019-2030)
 Figure 57. EMEA Enzalutamide Tablets Sales by Application (2019-2030) & (K Units)
 Figure 58. EMEA Enzalutamide Tablets Sales Market Share in Volume by Application (2019-2030)
 Figure 59. Europe Enzalutamide Tablets Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 60. Middle East Enzalutamide Tablets Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 61. Africa Enzalutamide Tablets Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 62. China Enzalutamide Tablets Sales in Volume Growth Rate 2019-2030 (K Units)
 Figure 63. China Enzalutamide Tablets Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 64. China Enzalutamide Tablets Sales by Type (2019-2030) & (K Units)
 Figure 65. China Enzalutamide Tablets Sales Market Share in Volume by Type (2019-2030)
 Figure 66. China Enzalutamide Tablets Sales by Application (2019-2030) & (K Units)
 Figure 67. China Enzalutamide Tablets Sales Market Share in Volume by Application (2019-2030)
 Figure 68. APAC Enzalutamide Tablets Sales in Volume Growth Rate 2019-2030 (K Units)
 Figure 69. APAC Enzalutamide Tablets Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 70. APAC Enzalutamide Tablets Sales by Type (2019-2030) & (K Units)
 Figure 71. APAC Enzalutamide Tablets Sales Market Share in Volume by Type (2019-2030)
 Figure 72. APAC Enzalutamide Tablets Sales by Application (2019-2030) & (K Units)
 Figure 73. APAC Enzalutamide Tablets Sales Market Share in Volume by Application (2019-2030)
 Figure 74. Japan Enzalutamide Tablets Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 75. South Korea Enzalutamide Tablets Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 76. China Taiwan Enzalutamide Tablets Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 77. Southeast Asia Enzalutamide Tablets Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 78. India Enzalutamide Tablets Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 79. Enzalutamide Tablets Value Chain
 Figure 80. Enzalutamide Tablets Production Process
 Figure 81. Channels of Distribution (Direct Vs Distribution)
 Figure 82. Bottom-up and Top-down Approaches for This Report
 Figure 83. Data Triangulation
 Figure 84. Key Executives Interviewed

Enzalutamide is an active pharmaceutical ingredient (API) used primarily in the treatment of prostate cancer. It is an androgen receptor inhibitor that works by blocking the action of androgens (male hormones like testosterone) on cancer cells, which can help slow the growth and spread of tumors.

The global Enzalutamide Tablets revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).

In Japan the Enzalutamide Tablets revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).

This report focuses on global and Japan Enzalutamide Tablets market, also covers the segmentation data of other regions in regional level and county level.

The global key players of Enzalutamide Tablets include Astellas/Pfizer, AURISCO, etc. The global five biggest players hold a share of % in 2023.

Enzalutamide Tablets market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Enzalutamide Tablets market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.

For Japan market, this report focuses on the Enzalutamide Tablets market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in Japan.

Market Segmentation

Chapter Outline
Chapter 1: Introduces Enzalutamide Tablets definition, global sales (volume and revenue), Japan market size, Japan percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Enzalutamide Tablets companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue and volume of Enzalutamide Tablets in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world. 
Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Enzalutamide Tablets sales, revenue, gross margin, and recent development, etc.
Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12: research findings and conclusion